Key Topics

Communications with the general public that may require nominated signatory review will generally fall into one of the following categories:

  • Consumer press announcements (working with the media is covered in detail in a separate module)
  • Information about areas of research and clinical trials that are being conducted

In this module we will cover disease awareness and reference information.
With respect to patients we will cover the following topics:

Before moving on a brief note about Corporate Advertising:

Corporate advertising e.g. advertising the company as opposed to its products is also allowable with the general public and does not fall within the scope of regulations on medicines advertising unless the content includes items related to medicines.

At AstraZeneca, corporate communications and advertising are out of scope for nominated Signatory review unless the content relates to our products, therapy areas or includes disease information related to those therapy areas.

Here are some examples of corporate advertising from gsk, Pfizer and Bayer: note that no products are mentioned – the companies cover their activities, ethos or research in very general terms.